Related Experiment Videos
[Clotting factor concentrates].
1Abteilung Hämatologie und Onkologie, Medizinische Hochschule Hannover, Germany.
Hamostaseologie
|November 5, 2004
Summary
This survey reviews plasma-derived and recombinant coagulation factor concentrates, emphasizing careful consideration of their benefits versus potential short and long-term side effects for patients.
Area of Science:
- Hematology
- Pharmacology
Context:
- Focuses on coagulation factor concentrates, essential for managing bleeding disorders.
- Highlights the critical role of these therapies in patient care.
Purpose:
- To survey the indications and clinical use of plasma-derived and recombinant coagulation factor concentrates.
- To inform careful patient management by balancing treatment efficacy with potential adverse effects.
Summary:
- Reviews the application of plasma-derived and recombinant coagulation factor concentrates.
- Emphasizes the need for a risk-benefit assessment in individual patient cases.
- Discusses both therapeutic effectiveness and potential side effects.
Impact:
- Aids clinicians in optimizing the use of coagulation factor therapies.
- Promotes informed decision-making regarding substitution therapy.
- Contributes to improved patient safety and treatment outcomes.